Comparison of the differences between tilsiparatide and tilpotide

In fact, Tirzepatide and "Tirpotide" are essentially the same. They are different transliterations of the same drug name. Tisiparatide is a new glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) dual receptor agonist developed by Eli Lilly and Company. The Chinese standard translation is "tisiparatide". Some unofficial information or media will mistakenly write it as "Tilpotide" due to pronunciation, input method errors or translation habits, but its ingredients, mechanism and uses are exactly the same.

The uniqueness of tisiparatide lies in its "insulin dual synergy" mechanism: on the one hand, it simulates GLP-1, delaying gastric emptying, reducing appetite, and promoting insulin secretion; on the other hand, it activates GIP receptors, enhances the response of pancreatic beta cells, and improves insulin sensitivity. This "dual-target" design allows it to significantly promote weight loss while controlling type 2 diabetes. Clinical studiesSURPASS and SURMOUNT series show that the drug is better than semaglutide in reducing HbA1c, and can even achieve more than 15% in weight loss.

From the perspective of safety and adverse reactions, tilsiparatide may cause adverse reactions in the digestive system, such as nausea, vomiting, and diarrhea. However, the results of studies with tilsiparatide showed that it was generally well tolerated. Studies have shown that tilsiparatide does not significantly increase the risk of serious adverse events, which has important implications for clinical application.

Therefore, if patients see "Tilpotide" during the search process, they should know that it is another name for "Tilsipatide" and there is no difference in efficacy or ingredients between the two. Currently, the drug has been approved for type 2 diabetes in many countries and is also applying for indications for obesity. It is a highly anticipated new generation drug in the field of weight loss.

Reference materials:https://www.drugs.com/tirzepatide.html